US, WASHINGTON (ORDO NEWS) — Hopes for the emergence of a coronavirus vaccine pushed Japanese stocks to rise: the key Nikkei 225 index added about 2% on news of the first positive test results. At the start of trading, growth was generally 2.44%.
The locomotive of such dynamics was the shares of industrial automation equipment manufacturer Fanuc, which soared 4%.
However, Moderna was the conductor of the concert in major tones, which began on Asian trading floors, and announced the first results of a coronavirus vaccine test.
The American biotechnology company claims that all 45 test participants developed antibodies to the coronavirus thanks to the vaccine.
This news clearly encouraged Asian investors, so the broader Japanese stock index, Topix, added about 2%. South Korean Kospi has shown similar growth. Australian S & P / ASX 200 up 1.56%. Overall, the MSCI Asia ex-Japan index rose 0.77%.
Chinese President Xi Jinping’s statement that Beijing will allocate $ 2 billion in aid to COVID-19-affected countries added to the positive.
Contact us: [email protected]